Skip to content

Medicine 3.0 for men: How to make prevention your default

Veedma's editorial team avatar
Veedma's editorial team: Evidence-based men's health
Clinical rules by Vladimir Kotlov, MD, Founder & CEO at Veedma · How we check articles
Oct 09, 2026 · 12 min read
Medicine 3.0 for men: How to make prevention your default
Photo by Ketut Subiyanto on Pexels

To make prevention your default, Medicine 3.0 focuses on earlier risk testing, tracking trends over time, and making targeted lifestyle and medical changes before disease develops. It shifts the goal from being “normal” on paper to being optimal in real life so you can protect performance now and extend healthspan later.

Find the cause before treating it

Choose a lab panel and get a clinical review with clear next steps.

Order your lab panel

Key takeaways

  • Medicine 3.0 prioritizes prevention, acting on chronic disease risk years before a formal diagnosis instead of waiting for one.[1]
  • “Normal” labs are not always “optimal.” Screening for prediabetes and acting on it early can prevent or delay type 2 diabetes.[2]
  • Continuous glucose monitors can show how food and physical activity affect your glucose, although interpreting the data in people without diabetes still needs more research.[3]
  • A diagnosis of testosterone deficiency requires symptoms plus consistently low testosterone on repeat early morning tests, and LH and FSH are measured alongside testosterone so primary and secondary hypogonadism can be told apart before treatment.[4] [5]
  • For men with secondary or functional hypogonadism who want to preserve fertility, testosterone therapy is a poor fit because it suppresses sperm production.[5] Enclomiphene raised testosterone while maintaining sperm counts in men with secondary hypogonadism in a clinical trial.[6]

Why medicine 3.0 matters for men

Medicine 3.0 is a longevity oriented approach that shifts healthcare from treating disease to preventing it in the first place. For men, that matters because the biggest threats to both lifespan and day to day function tend to be chronic, slow moving conditions like type 2 diabetes, Alzheimer’s disease, cancer, and heart disease.

Medicine 2.0 is excellent in emergencies. If you rupture an appendix or break a bone, you want rapid diagnostics, surgery, and antibiotics. According to the Medicine 3.0 framework Peter Attia, MD, describes in his 2023 book Outlive, the classic model often waits until a man “qualifies” for a diagnosis before acting, even when the trajectory is predictable and preventable.[1]

There is also a human side. Medical gaslighting is when a clinician discounts or denies a patient’s symptoms, often when there is no simple explanation on standard testing. Medicine 3.0 tries to reduce that gap by spending more time, connecting systems, and using better measurement so a man’s story and his data match up.

How medicine 3.0 works in real life

It starts earlier, because chronic disease starts earlier

According to Attia’s description of Medicine 3.0, prevention means acting on chronic disease risk long before a formal diagnosis.[1] In this sense, prevention is a clinical strategy that uses testing and targeted changes to reduce risk while a man still feels fine.

Medicine 2.0 is built on the scientific method and on randomized clinical trials, which compare an intervention with a control by assigning people by chance to reduce bias. Medicine 3.0 keeps that evidence base but moves the timing of care upstream.

It treats “normal” as a starting point, not the finish line

A core Medicine 3.0 idea is the move from “normal” to optimal. A reference range is a statistical description of a population, not a measure of how well an individual is doing. A fasting blood glucose that is technically normal can still be rising year after year.

The American Diabetes Association’s 2024 Standards of Care recommend identifying prediabetes because intervention at that stage can prevent or delay type 2 diabetes.[2] In a Medicine 3.0 mindset, a man and his clinician look at the pattern across several results, not a single lab value.

The same thinking applies to hormones. Testosterone deficiency evaluation starts with persistent symptoms and repeat morning blood tests. According to the 2018 Endocrine Society guideline, hypogonadism should be diagnosed only in men with consistent symptoms and signs and consistently low testosterone, confirmed by repeating a fasting morning total testosterone, with free testosterone measured by equilibrium dialysis or an accurate formula when total testosterone is near the lower limit of normal or SHBG is altered.[5] LH and FSH are measured alongside testosterone so the pattern can be classified as primary or secondary hypogonadism before treatment.[4] [5]

It uses technology to make your habits measurable

Medicine 3.0 leans on technology, including wearables, because feedback can change behavior. A wearable is a sensor that tracks things like sleep, heart rate, and activity. The aim is to connect cause and effect in daily life rather than chase perfect numbers.

A continuous glucose monitor is a small sensor that tracks glucose in near real time, usually from fluid under the skin. A 2022 review in Sensors on continuous glucose monitoring in healthy adults described possible uses in health care, wellness, and sports, including early detection of abnormal glucose regulation and learning how foods and physical activity affect glucose responses.[3] The authors also noted that more studies are needed to improve how these data are interpreted.[3]

It looks for root causes and connects body systems

Medicine 3.0 focuses on root causes, meaning the upstream drivers that keep a problem recurring, not only symptom suppression. Chronic acid reflux is a common example, and Medicine 2.0 often treats it with acid reducing medication alone. According to the 2022 American College of Gastroenterology guideline, proton pump inhibitors remain the medical treatment of choice for gastroesophageal reflux disease, and care also includes checking for alarm symptoms such as trouble swallowing, weight loss, gastrointestinal bleeding, or anemia, using lifestyle measures, and arranging endoscopy when indicated.[7] Microbiome testing is sometimes marketed in this space, but its clinical utility is limited, so it is best treated as investigational unless a clinician can tie it to a clear decision and follow up plan.

Medicine 3.0 also treats the body as connected systems rather than isolated organs. The gut microbiome is the community of microbes living in the digestive tract, and the gut brain axis links it with mood and cognition. A review and meta-analysis of gut microbiota studies found shared differences in microbiota composition across psychiatric disorders, including depression.[9] These findings are associations and do not show that the microbiome causes depression, but they are one reason digestive and mental health symptoms are worth considering together.

Conditions medicine 3.0 targets early in men

Medicine 3.0 is not a diagnosis. It is a strategy to reduce the odds that a man develops the conditions most likely to shorten lifespan and healthspan, meaning the years spent in generally good health.[1] In practice, it often centers on:

  • Prediabetes and type 2 diabetes risk. Prediabetes is blood glucose above normal but below the diabetes threshold. Identifying it early matters because intervention at this stage can prevent or delay type 2 diabetes.[2]
  • Cardiovascular risk that is missed by basic panels. According to the 2019 ESC/EAS dyslipidemia guidelines, apolipoprotein B (ApoB) is useful for risk assessment, particularly in people with high triglycerides, diabetes, obesity, or very low LDL cholesterol, because it reflects the number of atherogenic particles.[8] ApoB is the protein carried by each “atherogenic” particle that can enter artery walls.
  • Chronic reflux and gut driven symptoms. Persistent reflux should be evaluated and treated with guideline based steps, including lifestyle measures and endoscopy when indicated.[7]
  • Mental health symptoms with body system overlap. Meta-analytic evidence links gut microbiota patterns with psychiatric disorders in adults, which supports a systems view over siloed care.[9]
  • Low testosterone that is individualized. Repeat morning testosterone testing with LH and FSH helps separate primary, secondary, and functional patterns, which are not treated the same way.[4] [5]

Some tools grouped under Medicine 3.0, such as certain microbiome tests or broad screening technologies, are still evolving. Results can be hard to interpret and not every test leads to a decision, so the best use is targeted testing tied to a plan and follow up.

Symptoms and signals men should not ignore

Medicine 3.0 tries to act before symptoms appear, but most men seek care because something feels off. These signals deserve a prevention minded conversation and better measurement:

  • Fasting glucose creeping up over time even if each result was called “normal.” Ask whether you have been checked for prediabetes and what the next steps are.[2]
  • Chronic acid reflux symptoms that keep returning, especially if treatment is only symptom suppression without a broader look at drivers. For persistent symptoms, ask about alarm symptoms and when endoscopy is appropriate.[7]
  • Digestive symptoms paired with mood changes or stress that seems to “hit the gut.” These are worth raising together rather than in separate appointments.
  • Persistent symptoms that are dismissed because standard workups look fine. This is where medical gaslighting can occur, and where a patient centered approach can reduce harm.
  • Low testosterone concerns that are treated like a copy and paste problem. Symptoms such as low libido or fatigue call for repeat morning testing and a search for the cause, not a decision based on one number.[5]

What to do about it

In practice, Medicine 3.0 means measuring what matters, acting early, and adjusting over time.

  1. Start with smarter testing that matches your risks: Ask for prevention oriented labs that go beyond a basic annual panel, such as fasting glucose and, when your cardiovascular risk profile calls for it, ApoB.[8] If low testosterone is a concern, ask for repeat early morning testing that includes total testosterone, LH, and FSH, plus free testosterone, which matters most when total testosterone is borderline or SHBG is abnormal, so the pattern can be classified as primary or secondary hypogonadism before any treatment decision.[4] [5]
  2. Use lifestyle and targeted therapy, not just reassurance: Within Attia’s Medicine 3.0 framework, lifestyle is treated as a prescription: more exercise, better nutrition including micronutrient intake, fewer ultra processed foods, and about 8 hours of sleep.[1] For glucose trending high, discuss early intervention with your clinician. According to the ADA Standards of Care, metformin may be considered alongside intensive lifestyle change in selected adults with prediabetes.[2] For testosterone, treatment should match the classification and goals. Exogenous testosterone suppresses LH, FSH, and sperm production, and the Endocrine Society recommends against starting it in men planning fertility in the near term.[5] Enclomiphene works differently, blocking estrogen feedback at the hypothalamus so the body raises LH and its own testosterone. In a clinical trial comparing it with topical testosterone in men with secondary hypogonadism, oral enclomiphene raised testosterone and maintained sperm counts, while topical testosterone lowered sperm counts.[6] Enclomiphene does not suit primary hypogonadism, where the testes cannot respond to LH.
  3. Monitor, iterate, and avoid “set it and forget it” care: Continuous glucose monitors can help some men see how food and physical activity move glucose, which can guide everyday choices.[3] Pair that with scheduled rechecks of key labs so decisions rest on data rather than guesswork.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have, with results interpreted by licensed providers. When appropriate, they prescribe enclomiphene or the enclomiphene plus tadalafil tablet, and in Veedma’s protocol enclomiphene is first-line for secondary hypogonadism. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

Myth vs fact

Myth: If my lab is “normal,” I do not need to think about it.

Fact: Medicine 3.0 treats “normal” as a range and focuses on your trend, your symptoms, and what is optimal for long term health.

Myth: Wearables are just toys for fitness guys.

Fact: For some men, tracking sleep, activity, or glucose creates feedback that makes prevention strategies easier to execute.

Myth: Reflux is just too much stomach acid, so blocking acid fixes the problem.

Fact: Symptom control can help, but persistent reflux still deserves guideline based evaluation, including lifestyle measures and appropriate testing, rather than endless “quick fixes.”

Myth: Low testosterone always means you need testosterone injections right away.

Fact: Diagnosis requires persistent symptoms plus consistently low testosterone on repeat morning tests, with LH and FSH used to classify primary vs secondary hypogonadism before treatment.[4] [5] Testosterone therapy suppresses sperm production, and the Endocrine Society recommends against it for men planning fertility soon.[5] Men with secondary hypogonadism who want to preserve fertility can ask about options such as enclomiphene.[6]

Myth: If a doctor cannot find a cause quickly, my symptoms are not real.

Fact: Medical gaslighting is a known problem. A patient centered approach and better measurement can close the gap between symptoms and diagnosis.

Bottom line

Medicine 3.0 is a practical shift for men who want to stay strong and sharp for decades. Start earlier than you think, treat “normal” as incomplete, use technology for feedback, and target root causes across systems. Ask a clinician who is comfortable with prevention focused care to build an individualized plan based on your risk factors, symptoms, and repeat measurements, with clear follow up and monitoring.

References

  1. Attia P, Gifford B. Outlive: The Science and Art of Longevity. Harmony; 2023.
  2. American Diabetes Association Professional Practice Committee. 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S43-S51.
  3. Holzer R, Bloch W, Brinkmann C. Continuous Glucose Monitoring in Healthy Adults-Possible Applications in Health Care, Wellness, and Sports. Sensors (Basel). 2022;22. PMID: 35271177
  4. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432. PMID: 29601923
  5. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
  6. Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with secondary hypogonadism: comparison with topical testosterone. Fertility and sterility. 2013;99:1328-1335.e7.
  7. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117:27-56. PMID: 34807007
  8. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111-188. PMID: 31504418
  9. Nikolova VL, Hall MRB, Hall LJ, Cleare AJ, Stone JM, Young AH. Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis. JAMA psychiatry. 2021;78:1343-1354.

Start with a lab panel

Get a clinical review of your results and health history, with an explanation of the decision and next steps in your patient chat. If you are eligible and want treatment, choose a plan and save a card to book a video visit at no extra visit fee. Treatment billing starts only if prescribed.

Order your lab panel
Veedma's editorial team

Veedma's editorial team: Evidence-based men's health

The Veedma editorial team writes evidence-based men's health content with AI-assisted research tools, under clinical rules set by Vladimir Kotlov, MD, urologist, CEO and founder of Veedma. Every article passes automated checks before publication and is re-checked periodically. Read our editorial policy.